Released: Annual Asian Biopharmaceutical Industry Report
1600 industry professionals shared views about their opinions and interests in Asia’s biopharma industry. In the report, we discovered that partnering with local Asian and global Asian pharmas and biotechs continues to be the top area of interest and concern for the Asian biopharmaceutical industry. The report gave us a glimpse of the heartbeat of the biopharmaceutical industry as all 1600 industry professionals shared what were the topics that would be relevant and key for the Asian biopharmaceutical industry and areas of interest.
It was a common consensus that China and Singapore was listed as the top 2 countries in Asia that would be important to the biopharmaceutical industry.